Raptor Announces Full Enrollment of Phase 2b Trial of RP103 for Non-Alcoholic Fatty Liver Disease in Children
January 13, 2014 07:00 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Jan. 13, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that its Phase 2b clinical trial, to evaluate the safety and potential efficacy of RP103...
Methuselah Foundation Announces $1 Million "New Organ Liver Prize" at World Stem Cell Summit
December 05, 2013 11:47 ET
|
Genetics Policy Institute
SAN DIEGO, Dec. 5, 2013 (GLOBE NEWSWIRE) -- Methuselah Foundation, a medical charity based in Springfield, VA, announced today at the World Stem Cell Summit in San Diego the official launch of the $1...
American Heart Association Comment: FDA Announces Safety Changes on Labeling for Some Statins
February 28, 2012 18:03 ET
|
American Heart Association
DALLAS, Feb. 28, 2012 (GLOBE NEWSWIRE) -- The United States Food and Drug Administration (FDA) announced it is revising safety information on the labels of some statins (cholesterol lowering...